関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Methyltryptamine | HCID 6088 | — |
| 反応物 | N-(3-chloropropyl)piperidine hydrochloride | HCID 79624 | — |
| 反応物 | 1-(3-Chloropropyl)-3-(4-methoxyphenyl)piperidine hydrochloride | HCID 18001209 | — |
| 生成物 | (2-Indol-3-ylethyl)methyl(3-piperidylpropyl)amine Hydrochloride | HCID 70038108 | — |
反応手順
Using 3-(2-methylaminoethyl)indole (123 mg, 0.70 mmol) and 1-(3-chloropropyl)piperidine hydrochloride (198 mg, 1.0 mmol) instead of 4-(3-indolyl)piperidine and 1-(3-chloropropyl)-3-(4-methoxyphenyl)piperidine hydrochloride respectively, reaction and concentration were carried out in the same procedure as Example 2. The resulting crude product was purified by column chromatography on a silica gel (silica gel NH-DM 1020 produced by Fuji Silysia Chemical Ltd., eluent; hexane:ethyl acetate=1:1) to afford a free form (166 mg) of the title compound as a pale yellow viscous oil. After adding hydrochloric acid/methanol to a solution of the free form in methanol, the mixture was concentrated and was then reprecipitated with methanol/ether to afford the title compound (167 mg, yield: 64%) as a pale yellow crystalline powder.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US06642228B1 |
|---|
| 出典データセット | uspto-grants-2003_11 |
|---|
| ORD ID | ord-56eef1aae78645eda9dc05bd421b5a5b |
|---|
| 出典メモ | uspto-grants-2003_11 |
|---|